Literature DB >> 12931819

Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis.

J K Ellington1, M Harris, L Webb, B Smith, T Smith, K Tan, M Hudson.   

Abstract

Staphylococcus aureus is the bacterial pathogen which is responsible for approximately 80% of all cases of human osteomyelitis. It can invade and remain within osteoblasts. The fate of intracellular Staph. aureus after the death of the osteoblast has not been documented. We exposed human osteoblasts to Staph. aureus. After infection, the osteoblasts were either lysed with Triton X-100 or trypsinised. The bacteria released from both the trypsinised and lysed osteoblasts were cultured and counted. Colonies of the recovered bacteria were then introduced to additional cultures of human osteoblasts. The number of intracellular Staph. aureus recovered from the two techniques was equivalent. Staph. aureus recovered from time zero and 24 hours after infection, followed by lysis/trypsinisation, were capable of invading a second culture of human osteoblasts. Our findings indicate that dead or dying osteoblasts are capable of releasing viable Staph. aureus and that Staph. aureus released from dying or dead osteoblasts is capable of reinfecting human osteoblasts in culture.

Entities:  

Mesh:

Year:  2003        PMID: 12931819

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  50 in total

Review 1.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Induction of Nod1 and Nod2 intracellular pattern recognition receptors in murine osteoblasts following bacterial challenge.

Authors:  Ian Marriott; Dana M Rati; Samuel H McCall; Susanne L Tranguch
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Intra-cellular Staphylococcus aureus alone causes infection in vivo.

Authors:  T Hamza; M Dietz; D Pham; N Clovis; S Danley; B Li
Journal:  Eur Cell Mater       Date:  2013-07-08       Impact factor: 3.942

Review 4.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

5.  Survival of Staphylococcus epidermidis in Fibroblasts and Osteoblasts.

Authors:  Kimberly Perez; Robin Patel
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

Review 6.  Nanomedicine for safe healing of bone trauma: Opportunities and challenges.

Authors:  Shahed Behzadi; Gaurav A Luther; Mitchel B Harris; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Biomaterials       Date:  2017-09-04       Impact factor: 12.479

7.  Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-01-10       Impact factor: 7.328

8.  Interaction of Staphylococcus aureus with osteoblasts (Review).

Authors:  Sifeng Shi; Xianlong Zhang
Journal:  Exp Ther Med       Date:  2011-12-20       Impact factor: 2.447

9.  Effect of thioridazine on experimental cutaneous staphylococcal infections.

Authors:  Beth L Hahn; Peter G Sohnle
Journal:  In Vivo       Date:  2014 Jan-Feb       Impact factor: 2.155

10.  Novel anti-infective activities of chitosan immobilized titanium surface with enhanced osteogenic properties.

Authors:  Niranjan Ghimire; Jie Luo; Ruogu Tang; Yuyu Sun; Ying Deng
Journal:  Colloids Surf B Biointerfaces       Date:  2014-07-03       Impact factor: 5.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.